Skip to main content

Advertisement

Log in

Factor VII Deficiency, Masked by Warfarin Therapy, as a Cause of Bleeding After Cardiovascular Intervention

  • Letter to the Editor
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Lip GY, Andreotti F, Fauchier L et al (2011) Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 13:723–746

    Article  PubMed  Google Scholar 

  2. Ahmed I, Gertner E, Nelson WB et al (2010) Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm 7:745–749

    Article  PubMed  Google Scholar 

  3. Alexander B (1959) Clotting factor VII (proconvertin): synonymy, properties, clinical and clinicolaboratory aspects. N Engl J Med 260:1218–1222

    Article  PubMed  CAS  Google Scholar 

  4. Jayandharan GR, Viswabandya A, Nair SC et al (2007) Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients. Haematologica 92(7):1002–1003

    Article  PubMed  CAS  Google Scholar 

  5. Mariani G, Dolce A, Napolitano M et al (2012) Invasive procedures and minor surgery in factor VII deficiency. Haemophilia 18:e63–e65

    Article  PubMed  CAS  Google Scholar 

  6. Raskob GE, Durica S, Morrissey JH, Owen WL, Comp PC (1995) Effect of treatment with low-dose warfarin-aspirin on activated Factor VI1. Blood 85(11):3034–3039

    PubMed  CAS  Google Scholar 

  7. Sakata T, Kario K, Matsuo T, Katayama Y, Matsuyama T, Kato H, Miyata T (1995) Suppression of plasma-activated factor VII levels by warfarin therapy. Arterioscler Thromb Vasc Biol 15(2):241–246

    Article  PubMed  CAS  Google Scholar 

  8. Palareti G, Legnani C (1996) Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 30(4):300–313

    Article  PubMed  CAS  Google Scholar 

  9. Robinson M, Healey JS, Eikelboom J et al (2009) Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 32:378–382

    Article  PubMed  Google Scholar 

  10. Haghpanah S, Vafafar A, Golzadeh MH et al (2011) Use of Glubran 2 and Glubran tissue skin adhesive in patients with hereditary bleeding disorders undergoing circumcision and dental extraction. Ann Hematol 90:463–468

    Article  PubMed  CAS  Google Scholar 

  11. Gandini R, Angelopoulos G, Konda D et al (2008) Transcatheter embolization of a large symptomatic pelvic arteriovenous malformation with Glubran 2 acrylic glue. Cardiovasc Intervent Radiol 31(5):1030–1033

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

Francesco Sbrana, Michele Coceani, Luca Panchetti, Emilio Maria Pasanisi, Daniele Rovai, and Andrea Del Corso have no conflict of interest to report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Sbrana.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sbrana, F., Coceani, M., Panchetti, L. et al. Factor VII Deficiency, Masked by Warfarin Therapy, as a Cause of Bleeding After Cardiovascular Intervention. Cardiovasc Intervent Radiol 36, 1180–1183 (2013). https://doi.org/10.1007/s00270-012-0521-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-012-0521-y

Keywords

Navigation